Switch to:
Bioanalytical Systems Inc (NAS:BASI)
EV/EBITDA
5.94 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Bioanalytical Systems Inc's enterprise value is $16.70 Mil. Bioanalytical Systems Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2015 was $2.81 Mil. Therefore, Bioanalytical Systems Inc's EV/EBITDA ratio for today is 5.94.

BASI' s EV/EBITDA Range Over the Past 10 Years
Min: -63.2   Max: 74.6
Current: 5.95

-63.2
74.6

During the past 13 years, the highest EV/EBITDA Ratio of Bioanalytical Systems Inc was 74.60. The lowest was -63.20. And the median was 8.80.

BASI's EV/EBITDA is ranked higher than
87% of the 179 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 14.20 vs. BASI: 5.95 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Bioanalytical Systems Inc's stock price is $1.40. Bioanalytical Systems Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2015 was $0.07. Therefore, Bioanalytical Systems Inc's P/E Ratio for today is 20.00.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Bioanalytical Systems Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=16.704/2.81
=5.94

Bioanalytical Systems Inc's current Enterprise Value is $16.70 Mil.
Bioanalytical Systems Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2015 was 0.641 (Dec. 2014 ) + 0.579 (Mar. 2015 ) + 1.907 (Jun. 2015 ) + -0.317 (Sep. 2015 ) = $2.81 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Bioanalytical Systems Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=1.40/0.07
=20.00

Bioanalytical Systems Inc's share price for today is $1.40.
Bioanalytical Systems Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2015 was 0.01 (Dec. 2014 ) + -0.01 (Mar. 2015 ) + 0.16 (Jun. 2015 ) + -0.09 (Sep. 2015 ) = $0.07.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Bioanalytical Systems Inc Annual Data

Sep06Sep07Sep08Sep09Sep10Sep11Sep12Sep13Sep14Sep15
ev2ebitda 14.538.059.12-7.9241.414.79-5.475.5224.086.78

Bioanalytical Systems Inc Quarterly Data

Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15
ev2ebitda 23.245.5211.6712.0215.2724.0813.5310.866.746.78
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK